Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

ADIL Adial Pharmaceuticals Inc

1,79

0,09 (5,29%)

02 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Adial Pharmaceuticals (NASDAQ:ADIL)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Adial Pharmaceuticals Charts.

Adial Pharmaceuticals (NASDAQ:ADIL)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Adial Pharmaceuticals Charts.

News Adial Pharmaceuticals Inc

Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office
Montag 22 April 2024 (1 Woche vor) • GlobeNewswire Inc.

Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
Mittwoch 10 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update
Dienstag 2 April 2024 (4 Wochen vor) • GlobeNewswire Inc.

Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
Samstag 2 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office
Mittwoch 28 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office
Dienstag 13 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Donnerstag 25 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Donnerstag 25 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 18 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Adial Announces Appointment of Tony Goodman as Chief Operating Officer
Donnerstag 18 Januar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 16 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Adial Pharmaceuticals Inc News-Artikel

Health Care Select Sector

JP Morgan Chase

BNP Paribas (QX)

Euro vs Sterling

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen